netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Introduction

Welcome to the formulary

Useful Links

 

SE London Area Prescribing Committee homepage

Compliance with NICE technology appraisals

 

 

otcmedicines

Prescribing of over-the-counter medicines

(SE London position statement)

 

 

News Feed

May 19 - MHRA Drug Safety Update: Lemtrada (alemtuzumab) and serious cardiovascular and immune-mediated adverse reactions: new restrictions to use and strengthened monitoring requirements


May 19 - MHRA Drug Safety Update: Tofacitinib (Xeljanz▼): restriction of 10 mg twice-daily dose in patients at high risk of pulmonary embolism while safety review is ongoing


May 19 - MHRA Drug Safety Update: Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy


May 19 - APC recommendation: Naloxone nasal spray 1.8mg (Nyxoid™) for the immediate emergency treatment of known or suspected opioid overdose


May 19 - APC recommendation: Buvidal® (buprenorphine) prolonged-release solution for injection (weekly or monthly injection) for the treatment of opioid dependence


May 19 - APC guidance: South East London Guideline for the Management of cows’ milk protein allergy in Primary Care


>>> more news

Welcome to the South East London Joint Medicines Formulary

This formulary is a prescribing list that includes the names of medicines approved by the Joint Formulary Committee and South East London Area Prescribing Committee for use at:

  • Guy’s and St Thomas’ NHS Foundation Trust (GSTFT)
  • King’s College Hospital NHS Foundation Trust (KCH)
  • Lewisham and Greenwich NHS Trust (LGT)
The availability of medicines approved by the Joint Formulary Committee and Area Prescribing Committee is subject to funding arrangements and clinical practice in individual Trusts. Availability in each Trust is indicated with each drug entry. For formulary products used less commonly, there maybe a 24-hour delay before the product is available on site as stocks may not be routinely kept.

This formulary does not contain the information necessary for prescribing, dispensing or administration. It should be used in conjunction with the British National Formulary (BNF), supplemented as necessary from specialist publications and manufacturers’ Summaries of Product Characteristics (SPC), local guidelines and national guidelines. It is intended for use by prescribers who have the necessary training and experience to interpret the information it provides.

Supplementary information is available from local Medicines Information/Formulary services:

  • Guy’s and St Thomas’ NHS Foundation Trust (Medicines Information extensions 83849, 83855, 88750; Formulary extension 83854 - outside line 020 7188 3854)
  • King’s College Hospital NHS Foundation Trust (extension 30355)
  • Lewisham and Greenwich NHS Trust (Medicines Information 020 8836 4900; Formulary 020 8836 4847).

Unlicensed medicines/uses

Unlicensed medicines or uses of licensed products that fall outside the marketing authorisation have been included for use in specific clinical settings, where these have been approved for formulary inclusion. Prescribers must take full responsibility for prescribing such products and comply with the Unlicensed Medicines Policy as approved at individual Trust level.

Disclaimer

Every attempt has been made to ensure that the information in this formulary is correct, but errors may have occurred.   Where there is doubt, information should be verified against relevant specialist publications


NetFormulary
   Visits = 162181
   Last updated: 24/05/2019 16:21:13
    Download net formulary from Apple IOS Store  Google Play net formulary